Berrens L, van Liempt P M
Clin Exp Immunol. 1974 Aug;17(4):703-7.
Synthetic conjugates of β-lactoglobulin and reducing sugar prepared by Maillard reaction acquire the capacity of inactivating haemolytic complement in human serum. The C-inactivating potential is related to the mean number of (lysine)-ε-amino-1-deoxy-2-ketose residues incorporated in the model compound. These findings are compared to results obtained by skin-testing similar artificial allergens in atopic subjects.
通过美拉德反应制备的β-乳球蛋白与还原糖的合成结合物具有使人血清中的溶血补体失活的能力。补体失活潜力与模型化合物中掺入的（赖氨酸）-ε-氨基-1-脱氧-2-酮糖残基的平均数有关。将这些发现与在特应性受试者中对类似人工过敏原进行皮肤测试所获得的结果进行了比较。
